Vitiligo itself is a skin condition and does not directly damage the internal organs. However, it is an autoimmune disease, and its presence indicates an increased risk for other autoimmune disorders that can affect internal organs.
Most commonly vitiligo affects the skin around the eyes, mouth, elbows, wrists, hands and ankles. The condition can sometimes involve large areas of skin, but it is rare for people to lose all of their skin pigment.
Predisposition to autoimmune conditions: People with vitiligo may be more likely to get other autoimmune conditions that affect how their body's immune system functions. Common autoimmune conditions include hypothyroidism, diabetes and anemia.
Other co-morbidities including obesity and kidney injuries were found to have a significant association with vitiligo. It was found that vitiligo patients had an increased risk of developing obesity and renal diseases in comparison with the control group.
People with vitiligo may be at increased risk of:
People with vitiligo also have an increased risk of inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn's disease. Both Crohn's and ulcerative colitis can cause persistent diarrhea, weight loss, bloody stools, fatigue, and abdominal pain. IBD symptoms can be tough to manage.
About 15 to 25 percent of people with vitiligo are also affected by at least one other autoimmune disorder, particularly autoimmune thyroid disease, rheumatoid arthritis, type 1 diabetes, psoriasis , pernicious anemia, Addison disease, systemic lupus erythematosus, celiac disease, Crohn's disease, or ulcerative colitis ...
Insults to the liver can compromise any of these functions, affecting visceral organs, joints, gastrointesti- nal tissues, and the skin. Dermatologic signs of specific liver diseases include alopecia and vitiligo associated with autoimmune hepatitis, and xanthelasma in chronic cholestatic liver disease.
If your kidneys aren't working properly, you may notice one or more of the following signs:
Results: Some cutaneous diseases are clearly unique to this population. Of them, Lindsay's Nails, xerosis cutis, dryness of the skin, nephrogenic systemic fibrosis and acquired perforating dermatosis have been described in chronic kidney disease patients.
Vitiligo is a chronic autoimmune skin condition characterized by depigmentation due to the destruction of melanocytes. Recent research has identified potential links between vitiligo and alterations in both the gut and skin microbiomes.
Vitiligo may flare or spread due to: Stress. Sunburn, cuts, or other skin damage. Chemical exposure.
3. Avoid inflammatory foods for vitiligo.
A 10-year retrospective study involving 3,280 patients showed that comorbid autoimmune conditions occur in approximately 23% of vitiligo patients, including thyroid disease (TD), rheumatoid arthritis (RA), inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), and type 1 diabetes mellitus (35).
In this study, we found that most of the vitiligo patients had low vitamin D levels in comparison with the controls, and among a majority of them, the level was very low.
Conclusions: In vitiligo both axonal degeneration and nerve regeneration may occur, with the latter possibly being a reactive change to earlier axonal damage. These findings support the hypothesis that there is a neuronal component to this disease.
Generally, earlier stages are known as 1 to 3. And as kidney disease progresses, you may notice the following symptoms. Nausea and vomiting, muscle cramps, loss of appetite, swelling via feet and ankles, dry, itchy skin, shortness of breath, trouble sleeping, urinating either too much or too little.
Water is the best beverage for supporting kidney health. It helps flush out toxins, maintains electrolyte balance, and prevents dehydration. Drinking at least 8–10 glasses of water daily is essential for anyone in recovery, especially those enrolled in an Alcohol Treatment Program or Drug Rehab Programs.
When kidneys cannot remove waste from your body, a rash can develop. One rash that occurs in people who have end-stage kidney disease causes small, dome-shaped, and extremely itchy bumps. As these bumps clear, new ones can form. Sometimes, the small bumps join together to form rough, raised patches.
Early signs your liver is struggling often include persistent fatigue, unexplained weight loss, loss of appetite, nausea, abdominal pain/bloating (especially upper right), and itchy skin, with changes in urine/stool color and easy bruising also being key indicators, though sometimes symptoms are absent in early stages. Pay attention to changes like dark urine, pale stools, or jaundice (yellow skin/eyes), as these signal the liver isn't filtering toxins or processing bilirubin properly.
The "worst" autoimmune diseases are subjective but often ranked by severity, impact on life expectancy, and organ damage, with top contenders including Giant Cell Myocarditis (deadly heart inflammation), Vasculitis (blood vessel inflammation like GPA), Systemic Lupus Erythematosus (multi-organ attacks), Multiple Sclerosis (nervous system damage), and Type 1 Diabetes (pancreas destruction). These conditions can severely affect quality of life, cause permanent disability, and reduce lifespan if not managed effectively, though rare ones like Giant Cell Myocarditis are acutely fatal.
Limited studies show that the herb Ginkgo biloba may return skin color in people with vitiligo. Other small studies show that alpha-lipoic acid, folic acid, vitamin C and vitamin B-12 plus phototherapy may restore skin color for some people.
No Patch Vitilglo Tablets are used for managing skin health and pigmentation. The unique blend includes Phenylalanine, Coenzyme Q-10, Astaxanthin, N-Acetyl L-Cysteine, Picrorhiza Kurroa Extract, Curcumin and Silymarin Extract, each contributing to the effectiveness of the product.
Laboratory work for vitiligo may include the following: Thyroid panel consisting of thyroid-stimulating hormone (TSH), free triiodothyronine (T3), and free thyroxine (T4) levels. Antinuclear antibody. Antithyroid peroxidase antibody.
Vitiligo is a common autoimmune disorder characterized by melanocyte destruction, leading to depigmented patches. It is often associated with other autoimmune diseases, including thyroid disease and systemic lupus erythematosus.